175 related articles for article (PubMed ID: 37046696)
1. Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis.
Ognibene M; De Marco P; Amoroso L; Cangelosi D; Zara F; Parodi S; Pezzolo A
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046696
[TBL] [Abstract][Full Text] [Related]
2. Identification of recurrent 3q13.31 chromosomal rearrangement indicates
Martinez-Monleon A; Gaarder J; Djos A; Kogner P; Fransson S
Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36601748
[TBL] [Abstract][Full Text] [Related]
3. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
Ognibene M; De Marco P; Parodi S; Meli M; Di Cataldo A; Zara F; Pezzolo A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742955
[TBL] [Abstract][Full Text] [Related]
4. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
[TBL] [Abstract][Full Text] [Related]
5. Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients.
Ognibene M; Morini M; Garaventa A; Podestà M; Pezzolo A
Cancer Biol Ther; 2020 May; 21(5):391-399. PubMed ID: 31959052
[TBL] [Abstract][Full Text] [Related]
6. Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.
Fernández-Blanco B; Berbegall AP; Martin-Vañó S; Castel V; Navarro S; Noguera R
Neoplasia; 2021 Jan; 23(1):12-20. PubMed ID: 33190090
[TBL] [Abstract][Full Text] [Related]
7. Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.
Pezzolo A; Sementa AR; Lerone M; Morini M; Ognibene M; Defferrari R; Mazzocco K; Conte M; Gigliotti AR; Garaventa A; Pistoia V; Varesio L
Cancer Biol Ther; 2017 May; 18(5):285-289. PubMed ID: 28402723
[TBL] [Abstract][Full Text] [Related]
8. Distribution of segmental chromosomal alterations in neuroblastoma.
Juan Ribelles A; Gargallo P; Ferriol C; Segura V; Yáñez Y; Juan B; Cañada AJ; Font de Mora J; Cañete A; Castel V
Clin Transl Oncol; 2021 Jun; 23(6):1096-1104. PubMed ID: 32948984
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma after childhood: prognostic relevance of segmental chromosome aberrations, ATRX protein status, and immune cell infiltration.
Berbegall AP; Villamón E; Tadeo I; Martinsson T; Cañete A; Castel V; Navarro S; Noguera R
Neoplasia; 2014 Jun; 16(6):471-80. PubMed ID: 25077701
[TBL] [Abstract][Full Text] [Related]
10. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Amoroso L; Ognibene M; Morini M; Conte M; Di Cataldo A; Tondo A; D'Angelo P; Castellano A; Garaventa A; Lasorsa VA; Podestà M; Capasso M; Pezzolo A
Genes Chromosomes Cancer; 2020 May; 59(5):277-285. PubMed ID: 31756773
[TBL] [Abstract][Full Text] [Related]
11. Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma.
Richard S; Tachon G; Milin S; Wager M; Karayan-Tapon L
Cancer Med; 2020 Sep; 9(17):6344-6353. PubMed ID: 32666673
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
[TBL] [Abstract][Full Text] [Related]
13. Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization.
Altura RA; Maris JM; Li H; Boyett JM; Brodeur GM; Look AT
Genes Chromosomes Cancer; 1997 Jul; 19(3):176-84. PubMed ID: 9218999
[TBL] [Abstract][Full Text] [Related]
14. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study).
Schleiermacher G; Michon J; Ribeiro A; Pierron G; Mosseri V; Rubie H; Munzer C; Bénard J; Auger N; Combaret V; Janoueix-Lerosey I; Pearson A; Tweddle DA; Bown N; Gerrard M; Wheeler K; Noguera R; Villamon E; Cañete A; Castel V; Marques B; de Lacerda A; Tonini GP; Mazzocco K; Defferrari R; de Bernardi B; di Cataldo A; van Roy N; Brichard B; Ladenstein R; Ambros I; Ambros P; Beiske K; Delattre O; Couturier J
Br J Cancer; 2011 Dec; 105(12):1940-8. PubMed ID: 22146831
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
16. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification.
Defferrari R; Mazzocco K; Ambros IM; Ambros PF; Bedwell C; Beiske K; Bénard J; Berbegall AP; Bown N; Combaret V; Couturier J; Erminio G; Gambini C; Garaventa A; Gross N; Haupt R; Kohler J; Jeison M; Lunec J; Marques B; Martinsson T; Noguera R; Parodi S; Schleiermacher G; Tweddle DA; Valent A; Van Roy N; Vicha A; Villamon E; Tonini GP
Br J Cancer; 2015 Jan; 112(2):290-5. PubMed ID: 25356804
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.
Parodi F; Passoni L; Massimo L; Luksch R; Gambini C; Rossi E; Zuffardi O; Pistoia V; Pezzolo A
OMICS; 2011 Mar; 15(3):113-21. PubMed ID: 21319993
[TBL] [Abstract][Full Text] [Related]
18. Radiogenomics of neuroblastomas: Relationships between imaging phenotypes, tumor genomic profile and survival.
Brisse HJ; Blanc T; Schleiermacher G; Mosseri V; Philippe-Chomette P; Janoueix-Lerosey I; Pierron G; Lapouble E; Peuchmaur M; Fréneaux P; Galmiche L; Algret N; Peycelon M; Michon J; Delattre O; Sarnacki S
PLoS One; 2017; 12(9):e0185190. PubMed ID: 28945781
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis.
Gasparotto D; Vukosavljevic T; Piccinin S; Barzan L; Sulfaro S; Armellin M; Boiocchi M; Maestro R
Int J Cancer; 1999 Aug; 84(4):432-6. PubMed ID: 10404099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]